Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC8425258/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC8425258/. The analysis below is for the second page.

Title[redir]:
PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis - PMC
Description:
The aim of the study was to study a nanoliposomal anti-PCSK9 vaccine as a novel approach for cholesterol lowering via PCSK9 inhibition. An immunogenic peptide construct termed immunogenic fused PCSK9-tetanus (IFPT) was displayed on the surface of ...

Matching Content Categories {📚}

  • Education
  • Science
  • Politics

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,005 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Ncbi.nlm.nih.gov might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

mice, pcsk, doi, vaccine, control, lifpta, google, scholar, ldlc, group, pubmed, vaccinated, atherosclerosis, plasma, antibodies, hypercholesterolemic, levels, figure, cbl, ldlr, cholesterol, antibody, study, antipcsk, peptide, weeks, significant, cells, compared, ifpta, longterm, vaccination, pmc, lifpt, titers, ifpt, formulations, lesions, cell, analysis, data, approach, free, lesion, hypercholesterolemia, nanoliposomal, vaccines, groups, model, liposomal,

Topics {✒️}

a-q-y-i-k-a-n-s-k-f-i-g-i-t-e s-i-p-w-n-l-e-r-i-t-p-v 2-distearoyl-sn-glycero-3-phosphoethanolamine-n-[maleimide hrp-conjugated anti-ldlr pro-inflammatory ifn-γ cytokine peptide-based anti-pcsk9 vaccines apolipoprotein-e-deficient mice apolipoprotein e-knockout mice 2-dimyristoyl-sn-glycero-3-phosphorylglycerol 2-dimyristoyl-sn-glycero-3-phosphorylcholine liposomal anti-pcsk9 vaccine low-density lipoprotein cholesterol increased anti-inflammatory response high-density lipoprotein cholesterol nanoliposomal anti-pcsk9 vaccine subtypes showing pro-atherogenic anti-inflammatory th2 cells vaccine-based pcsk9 suppression vaccine-provoked pcsk9 antibodies l-ifpta+ vaccine induced l-ifpta+ vaccine exhibited peptide-based antipcsk9 vaccines proprotein convertase subtilisin l-ifpta+ vaccine inhibited anti-pcsk9 vaccine formulations pmc beta search functional pcsk9-specific antibodies anti-β actin antibody vaccine-generated antibodies e-stained grade l-ifpta+ vaccine group peptide-based active vaccination pre-vaccination time point p-407-induced mouse model placebo-controlled descartes study l-ifpta+-vaccinated mice compared safe pcsk9-specific antibodies lipid-film hydration approach construct vaccine formulation fda-approved pcsk9 mabs l-ifpta+ vaccine resulted long-term statin therapy vitro pcsk9-ldlr binding long-term ldlc management l-ifpta+ vaccine observed inf-γ cytokine level anti-inflammatory cells greatest igg titers suppress pcsk9-ldlr interaction vaccine-induced antibodies

Questions {❓}

  • How do we improve patient compliance and adherence to long-term statin therapy?
  • New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?

External Links {🔗}(97)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.33s.